Related Experiment Video
Updated: Jun 24, 2026

Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity
Published on: March 5, 2020
Rhynchophylline from Uncaria rhynchophylla functionally turns delayed rectifiers into A-Type K+ channels
Chun-Hsiao Chou1, Chi-Li Gong, Chia-Chia Chao
1Department of Physiology, Graduate Institute of Neural and Cognitive Sciences, China Medical University, Taichung 40402, Taiwan, Republic of China.
Rhynchophylline, a compound from Uncaria rhynchophylla, accelerates slow inactivation of voltage-gated potassium (Kv) channels. This neuroprotective agent acts extracellularly, altering channel function and potentially impacting neuronal excitability.
Area of Science:
- Neuropharmacology
- Ion Channel Physiology
- Traditional Chinese Medicine
Background:
- Uncaria rhynchophylla is a traditional Chinese herb with known neuroprotective properties.
- Voltage-gated potassium (Kv) channels play critical roles in neuronal excitability and function.
- Rhynchophylline is a key alkaloid isolated from Uncaria rhynchophylla.
Purpose of the Study:
- To investigate the effects of Rhynchophylline on voltage-gated potassium (Kv) channel slow inactivation.
- To determine the site of action (extracellular vs. intracellular) of Rhynchophylline on Kv channels.
- To elucidate the functional consequences of Rhynchophylline's interaction with Kv channels.
Main Methods:
- Electrophysiological recordings (patch-clamp) in mouse neuroblastoma N2A cells.
- Application of Rhynchophylline extracellularly and via intracellular dialysis.
- Heterologous expression of Kv1.2 channels in HEK293 cells to study specific channel subtypes.
Main Results:
- Extracellular application of Rhynchophylline (30 microM) accelerated Kv current decay and shifted the steady-state inactivation curve leftward.
- Intracellular dialysis of Rhynchophylline did not affect current decay, indicating an extracellular site of action.
- Rhynchophylline accelerated slow inactivation and shifted the activation curve leftward for Kv1.2 channels, functionally converting delayed rectifiers to A-type channels.
Conclusions:
- Rhynchophylline acts extracellularly to accelerate Kv channel slow inactivation.
- This compound significantly alters Kv channel gating properties, shifting them towards A-type channel characteristics.
- Rhynchophylline's modulation of Kv channels may underlie its observed neuroprotective effects.
More Related Videos
08:39Whole-cell Patch-clamp Recordings for Electrophysiological Determination of Ion Selectivity in Channelrhodopsins
Published on: May 22, 2017
07:19Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique
Published on: February 7, 2025
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...